Increased FGF23 protects against detrimental cardio-renal consequences during elevated blood phosphate in CKD

The phosphaturic hormone FGF23 is elevated in chronic kidney disease (CKD). The risk of premature death is substantially higher in the CKD patient population, with cardiovascular disease (CVD) as the leading mortality cause at all stages of CKD. Elevated FGF23 in CKD has been associated with increas...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JCI Insight
Main Authors: Clinkenbeard, Erica L., Noonan, Megan L., Thomas, Joseph C., Ni, Pu, Hum, Julia M., Aref, Mohammad, Swallow, Elizabeth A., Moe, Sharon M., Allen, Matthew R., White, Kenneth E.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Clinical Investigation 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6478421/
https://ncbi.nlm.nih.gov/pubmed/30830862
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.123817
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados